Transmission and progression to disease of Mycobacterium tuberculosis phylogenetic lineages in The Netherlands by Guimarães, Hanna Nebenzahl et al.
Transmission and Progression to Disease of Mycobacterium
tuberculosis Phylogenetic Lineages in The Netherlands
Hanna Nebenzahl-Guimaraes,a,b,c Lilly M. Verhagen,d,e Martien W. Borgdorff,f,g Dick van Soolingena,h
National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlandsa; Life and Health Sciences Research Institute (ICVS), School of Health Sciences,
University of Minho, Braga, Portugalb; ICVS/3Bs, PT Government Associate Laboratory, Braga/Guimarães, Portugalc; Wilhelmina Children’s Hospital Utrecht, Utrecht, The
Netherlandsd; Laboratory of Pediatric Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlandse; Public Health Service, Amsterdam, The
Netherlandsf; Department of Clinical Epidemiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlandsg; Department of Medical
Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlandsh
The aim of this study was to determine if mycobacterial lineages affect infection risk, clustering, and disease progression among
Mycobacterium tuberculosis cases in The Netherlands. Multivariate negative binomial regression models adjusted for patient-
related factors and stratified by patient ethnicity were used to determine the association between phylogenetic lineages and in-
fectivity (mean number of positive contacts around each patient) and clustering (as defined by number of secondary cases within
2 years after diagnosis of an index case sharing the same fingerprint) indices. An estimate of progression to disease by each risk
factor was calculated as a bootstrapped risk ratio of the clustering index by the infectivity index. Compared to the Euro-Ameri-
can reference,Mycobacterium africanum showed significantly lower infectivity and clustering indices in the foreign-born popu-
lation, whileMycobacterium bovis showed significantly lower infectivity and clustering indices in the native population. Signifi-
cantly lower infectivity was also observed for the East African Indian lineage in the foreign-born population. Smear positivity
was a significant risk factor for increased infectivity and increased clustering. Estimates of progression to disease were signifi-
cantly associated with age, sputum-smear status, and behavioral risk factors, such as alcohol and intravenous drug abuse, but
not with phylogenetic lineages. In conclusion, we found evidence of a bacteriological factor influencing indicators of a strain’s
transmissibility, namely, a decreased ability to infect and a lower clustering index in ancient phylogenetic lineages compared to
their modern counterparts. Confirmation of these findings via follow-up studies using tuberculin skin test conversion data
should have important implications on M. tuberculosis control efforts.
Curbing tuberculosis (TB) transmission is a challenge in high-burden countries. However, even in low-prevalence settings,
controlling TB is an important requirement due to humanmigra-
tion from higher-incidence areas to Western countries (1). In
Western countries, studies on transmission are more feasible, as
all cases undergo extended diagnostic algorithms and all clinical
and demographic data are recorded. Current molecular typing
methods, such as variable number of tandem repeat (VNTR) typ-
ing and restriction fragment length polymorphism (RFLP) typing,
allow identification of clusters of Mycobacterium tuberculosis iso-
lates with identical genotypes that, in population-based studies,
reveal recent transmission (2, 3). Spoligotyping and VNTR typing
can identify the genotype family of the isolate, revealing bacterial
variation via the identification of phylogenetic lineages (4, 5).
While many studies have elucidated the variation in the dis-
ease’s spread and outcome attributable to host and environmental
factors, there is also evidence that bacterial factors may affect the
spread of tuberculosis (6). In The Netherlands, for example, one
study showed that the number of positive contacts around a case
increases with growing cluster size (7). In a subsequent study in
the same setting, cluster size growth was not different between
phylogenetic lineages after controlling for host risk factors (8).
However, this study could not distinguish between transmission
rates and progression to disease. There are, however, indications
that progression to disease is partly dependent on bacterial varia-
tion. It has, e.g., been postulated that someMycobacterium africa-
num strains might transmit equally well as other M. tuberculosis
complex strains but might be less associated with progression to
disease (9). We will refer to these two properties that affect the
degree of clustering as infectivity (the bacterium’s ability to estab-
lish an initial infection in the human host) and progression to
disease (the bacterium’s capacity to produce disease) (10).
In the low-incidence context of The Netherlands, with a glob-
ally representative cohort of patients, we aim to determine dif-
ferences in indices of infectivity, clustering, and estimated pro-
gression to disease of different mycobacterial lineages using
fingerprinting data and contact investigation. This will provide
insights into the role of bacteriological factors in TB transmission,
which itself may affect future TB control measures.
MATERIALS AND METHODS
Data collection andDNAfingerprinting.TheNational Institute for Pub-
lic Health and the Environment (RIVM) is a reference laboratory for
secondary laboratory diagnosis of all TB cases in The Netherlands, offer-
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ing identification, drug susceptibility testing, and molecular typing for
each TB case. DNA fingerprints of all nationwideM. tuberculosis complex
isolates and their cluster statuses have been stored in an RFLP/VNTR
database since 1993. The registration committee of The Netherlands Tu-
berculosis Register (NTR) approved this retrospective study and provided
anonymized demographic and clinical information for patients. Because
these data are deidentified by name, DNA fingerprinting results were
matched by sex, date of birth, year of diagnosis, and postal code. All
notified culture-positive cases of M. tuberculosis between 1993 and 2011
were included in the study. For patients with multiple isolates sharing
identical fingerprints, only the isolate with the earliest diagnosis date was
included. Contaminating isolates were excluded.
Isolates recovered from patients between 1993 and 2009 underwent
IS6110 typing and polymorphic GC-rich sequence (PGRS) RFLP typing
(n  15,073), and those from 2004 onward were subjected to VNTR
typing (n 5,870) (11, 12). In the period of 2004 to 2008, both RFLP and
24-locus VNTR typing were performed to obtain a smooth transition in
typing methods and to evaluate VNTR typing performance (3). In addi-
tion, 4,433 randomly selected isolates were spoligotyped (n 4,433). We
defined a cluster as a group of patients who sharedM. tuberculosis isolates
with identical RFLP or VNTR patterns or, if strains had fewer than five
IS6110 copies, identical PGRS RFLP patterns.
Conventional contact investigation. Systematic contact investigation
by TB Public Health Services in The Netherlands is conducted per the
stone-in-the-pond principle, in which the decision to extend conven-
tional contact investigation to the next ring of contacts is based on the
prevalence of infection in the investigated ring (13). Contacts are defined
by the frequency and intimacy of their contacts with the TB index case.
The tuberculin skin test (TST) is used to investigate presumably exposed
contacts. If the number of TST-positive contacts in the first ring suggests
a high spread of tuberculosis, a larger ring of contacts is investigated. We
have defined positive contacts as contacts with a TST induration10mm
and/or contacts who received a diagnosis of TB disease. If contact inves-
tigations become very large, identified TB infections and secondary cases
are less likely to be related to the index case. To minimize the probability
that positive contacts in our research were unrelated to the defined index
case, we only included contacts in the first ring around the index patient.
First-ring contacts are defined as contacts that are physically close to the
index patient, considering environmental factors, such as room size, ven-
tilation, air purification, and air circulation. In addition, the patient and
the contact must be able to indicate where they met and must have a
long-standing relationship to qualify as a first-ring contact. Examples of
first-ring contacts are household members, close work colleagues, and
close friends.
Classification into phylogenetic lineages. The phylogenetic lineages
of isolates were determined using a combination of spoligotyping, the
MIRU (mycobacterial interspersed repetitive unit) best match analysis
offered by the MIRU-VNTRplus online tool, and RFLP similarity, as de-
scribed in a previous study using the same data set (8, 14). Three species
(M. africanum,Mycobacterium bovis, andM. tuberculosis) and four major
phylogenetic lineages ofM. tuberculosis were identified: the Euro-Ameri-
can, Central Asian strain (CAS), East African Indian (EAI), and Beijing
genotypes. Strains not assigned a phylogenetic lineage or assigned tomul-
tiple major phylogenetic families per cluster were not analyzed. Strains
classified as either T or U (unknown) also were excluded due to the am-
biguity of these classifications.
Definitions. For our infectivity index, we took the mean number of
positive contacts around each patient who underwent contact investiga-
tion. We excluded patients with missing data on contact investigation or
those who had zero contacts investigated, as well as those for whom we
lacked ethnicity information. Because TB transmission almost exclusively
results from patients with pulmonary TB, we also excluded patients with
extrapulmonary TB, leaving us with a total of 2,809 cases (Fig. 1).
For our clustering index, we used the number of secondary cases oc-
curring within 2 years of the index case diagnosis. The 2-year cutoff has
been shown to best reflect recent transmission as opposed to disease re-
activation (1, 15).We defined index cases as patients who had strains with
RFLP or VNTR patterns not seen in other patients in the previous 2 years.
We searched for index cases based onRFLP-typing data from1995 to 2007
and for index cases based on VNTR typing from 2007 to 2009. We ex-
cluded RFLP-defined index cases from 1993 and 1994 and VNTR-defined
index cases from 2005 and 2006 (n 2,684), because we could not deter-
mine whether the strains of these index cases were unobserved in the
previous 2 years. Similarly, we excluded RFLP-defined index cases occur-
ring after 2007 and VNTR-defined index cases occurring after 2009 (n
950), because we could not follow these index cases for a full 2 years.
Secondary cases from these index cases (included in the counts) were also
excluded. Finally, we excluded cases between 1995 and 2007 occurring2
years after a previous patient with the same RFLP fingerprint yet diag-
nosed 2 years after a cluster’s start (n  722) and cases occurring be-
tween 2007 and 2009 that occurred2 years after a previous patient with
the same VNTR fingerprint yet 2 years after a cluster’s start (n  40).
After excluding extrapulmonary cases, 4,432 patients remained: 2,881
nonclustered index patients, 607 index patients who were the first
patient of a cluster, and 944 secondary cases within 2 years of a cluster’s
start (Fig. 1).
Finally, estimates of progression to disease were calculated as risk ra-
tios (RR) of the population risk of disease given exposure to a risk factor by
the population risk of infection given exposure to the same risk factor
(dividing the clustering odds ratios [ORs] by the infectivity ORs).
Statistical analysis. We used a multivariate negative binomial re-
gression model to determine the association between phylogenetic lin-
eages and the infectivity and clustering indices. Since TST is poorly
specific among Mycobacterium bovis BCG contacts and positive TSTs
may represent old infections, we divided our data sets into native and
foreign-born (FB) cohorts in order to address important differences
between the two: FB patients are often BCG vaccinated (in contrast to
native Dutch patients, who are not), while the prevalence of infection
is higher among FB patients. Second-generation patients (born to FB
patients) were included in the native cohorts, given that, like native
patients, they are not BCG vaccinated and they have already been born
in a setting of lower prevalence of infection. Studies carried out in The
Netherlands have also previously demonstrated that contact investiga-
tion practices vary by demographic characteristics of the index patient
(16). As such, in both analyses, we adjusted for index patient-related
factors, including demographic, behavioral, and sputum smear status.
In addition, the logarithm of the number of investigated contacts
around a source case was used as an offset in the multivariate model
assessing the association between phylogenetic lineages and the spread
index, since the greater number of contacts around a source are inves-
tigated, the likelier it is to detect TST positive contacts. Variables with
P values of0.20 were entered into the multivariate model. Crude and
adjusted ORs are presented with 95% confidence intervals (CIs). Esti-
mates of TB progression were calculated for any risk factor that was
significant in either multivariate regression model. To calculate the
variance for the estimate of TB progression, we performed a bootstrap-
ping procedure, running our multivariate negative binomial regres-
sion models 10,000 times on bootstrapped data sets. The median of the
resulting 10,000 RRs was used as the estimate of TB progression, while
the 2.5th and 97.5th percentiles were used as the 95% cutoffs for the
estimate CI. All analyses were conducted using SAS (Windows version
9.3), SPSS program for Windows version 20.0 (SPSS Inc., Chicago, IL,
USA) and R (version 3.1.2 for Windows).
RESULTS
Between January 1993 and December 2011, 18,294 isolates were
collected from the same number of notified TB cases in TheNeth-
erlands, and their clustering statuses were ascertained, of which
15,601 (85%) were successfully matched with the NTR data. Of
these, 15,224 (98%) were noncontaminated M. tuberculosis cul-
Transmission of M. tuberculosis Phylogenetic Lineages
October 2015 Volume 53 Number 10 jcm.asm.org 3265Journal of Clinical Microbiology
 
tures with completely ascertained information on host risk fac-
tors. After phylogenetic lineage assignment, there were 10,738 iso-
lates that were M. bovis, M. africanum, or M. tuberculosis of the
Euro-American, Beijing, CAS, or EAI lineages (Fig. 1). The mean
age of the patients carrying these strains was 41 years (standard
deviation, 20 years); 6,394 (60%) were male; and 7,762 (72%)
were foreign born.
Mycobacterial genotypes. The Euro-American lineage was
predominant in both the infectivity (78% in native cohort; 56% in
FB cohort) and clustering (79% in native cohort; 64% in FB co-
hort) data sets. In contrast, both M. africanum and M. bovis rep-
resented less than 1% of all cases in the infectivity data set. In the
clustering data set, both M. africanum and M. bovis represented
only 2% of all cases (Tables 1 and 2).
Infectivity by mycobacterial lineage. The proportion of cases
in which a contact investigation was performed in The Nether-
lands was approximately equal between lineages, though slightly
lower in the FB cohort for Beijing and EAI compared to the native
counterpart (Fig. 2). The average number of TST-positive con-
tacts declined significantly in the 65 years age category in the
native cohort and in the20 years age category in the FB cohort.
Smear positivity was associated with an increased average number
of TST-positive contacts in both native and FB cohorts. There
were no significant differences in infectivity by gender, homeless-
ness, and alcohol use in the two cohorts, although use of intrave-
nous drugs in the native populations and rural residence in the FB
population were associated with a decreased average number of
TST-positive contacts. The mean number of TST-positive con-
tacts around an index casewas significantly lower forM.bovis than
for the Euro-American reference lineage in the native population
in multivariable analysis. In the FB population, M. africanum
and EAI presented a significantly lower number of TST-positive
contacts (Table 1).
Clustering by mycobacterial lineage. The number of second-
ary cases declined significantly with increasing age (65 years) in
both the native and FB cohorts. Smear positivity was also associ-
FIG 1 Flow-diagram of exclusion criteria applied to data set.
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atedwith an increased number of secondary cases in both cohorts,
and female gender was associated with an increased number of
secondary cases only among the FB. Rural residence was associ-
ated with a decreased number of secondary cases only in the FB
cohort. Relative to the Euro-American reference in the multivari-
able analysis, the number of secondary cases was significantly
lower for M. bovis in the native-born population and for M. afri-
canum in the FB population (Table 2).
Estimatesofprogression todiseasebymycobacterial lineage.
Estimates of progression to disease were significantly lower in
the 65 years age category in both ethnic cohorts and signifi-
cantly higher in the 0- to 19-years age category in the FB cohort.
Additionally, in the FB-born population, estimates of progres-
sion to disease were significantly lower in smear-negative pa-
tients. Both alcohol and drug abuse were significantly associ-
ated with higher estimates in the native population. No
TABLE 1 Risk factors among native and foreign-born index cases for infectivity (number of TST-positive contacts per index case)
Characteristic
Native cohort Foreign-born cohort
No. of
index
cases
Mean no. of
TST-positive
contacts/
index case
Univariate analysis
Multivariate
analysis,
relative no. (95%
CI)
No. of
index
cases
Mean no. of
TST-positive
contacts/
index case
Univariate analysis
Multivariate
analysis,
relative no.
(95% CI)
Relative no.
(95% CI) P
Relative no.
(95% CI) P
Age, yr 0.00 0.033
0–19 99 1.02 1.0 (0.68–1.6) 0.96 (0.65–1.4) 200 0.83 1.11 (0.83–1.5) 0.69 (0.53–0.89)
20–39 363 0.99 1 (Refa) 1 (Ref) 1024 0.75 1 (Ref) 1 (Ref)
40–64 339 0.82 0.83 (0.63–1.1) 0.91 (0.69–1.2) 459 0.60 0.81 (0.65–1.0) 0.96 (0.79–1.2)
65 207 0.51 0.51 (0.37–0.72) 0.50 (0.36–0.70) 118 0.49 0.66 (0.45–0.97) 0.80 (0.57–1.1)
Sex 0.15 0.32
Male 635 0.78 1 (Ref) 1 (Ref) 1,125 0.73 1 (Ref)
Female 373 0.93 1.2 (0.93–1.5) 1.0 (0.82–1.3) 676 0.66 0.73 (0.65–0.82)
Smear positivity 0.001 0.001
Negative 395 0.52 0.50 (0.39–0.65) 0.48 (0.38–0.62) 754 0.47 0.54 (0.45–0.65) 0.55 (0.46–0.65)
Positive 613 1.04 1 (Ref) 1 (Ref) 1,047 0.87 1 (Ref) 1 (Ref)
Lineage 0.00 0.006
Euro-American 786 0.91 1 (Ref) 1 (Ref) 1,157 0.75 1 (Ref) 1 (Ref)
Beijing 112 0.67 0.73 (0.50–1.1) 1.1 (0.77–1.6) 182 0.55 0.74 (0.54–1.0) 0.94 (0.71–1.2)
CAS 30 0.23 0.26 (0.11–0.61) 0.64 (0.27–1.5) 198 0.86 1.2 (0.86–1.5) 1.0 (0.79–1.3)
EAI 62 0.56 0.62 (0.37–1.04) 0.78 (0.47–1.3) 237 0.53 0.71 (0.54–0.94) 0.64 (0.49–0.83)
M. Africanum 5 0.40 0.44 (0.067–2.9) 0.44 (0.055–3.5) 15 0.27 0.36 (0.11–1.1) 0.30 (0.10–0.89)
M. bovis 13 0.23 0.25 (0.068–0.94) 0.23 (0.059–0.94) 12 0.17 0.22 (0.052–0.96) 0.51 (0.11–2.4)
Residency 0.07 0.002
Urban 690 0.90 1 (Ref) 1 (Ref) 1,067 0.79 1 (Ref) 1 (Ref)
Rural 318 0.70 0.78 (0.60–1.0) 0.78 (0.60–1.0) 734 0.58 0.74 (0.62–0.89) 0.71 (0.60–0.84)
Alcohol abuse 0.19 0.69
No 969 0.85 1 (Ref) 1 (Ref) 1,779 0.70 1 (Ref)
Yes 39 0.54 0.64 (0.33–1.2) 0.59 (0.30–1.2) 22 0.59 0.84 (0.36–1.9)
Drug abuse 0.01 0.97
No 953 0.86 1 (Ref) 1 (Ref) 1,722 0.70 1 (Ref)
Yes 55 0.40 0.47 (0.26–0.83) 0.43 (0.24–0.78) 79 0.71 1.0 (0.65–1.6)
Traveler to country
of endemicity
0.17 0.17
No 973 0.85 1 (Ref) 1 (Ref) 1,759 0.69 1 (Ref) 1 (Ref)
Yes 35 0.51 0.61 (0.30–1.2) 0.53 (0.25–1.1) 42 1.02 1.5 (0.83–2.6) 1.5 (0.88–2.4)
Homeless 0.72 0.94
No 978 0.84 1 (Ref) 1,753 0.70 1 (Ref)
Yes 30 0.73 0.88 (0.43–1.8) 48 0.69 0.98 (0.56–1.7)
Site of disease 0.21 0.099
Pulmonary 891 0.86 1 (Ref) 1 (Ref) 1,430 0.73 1 (Ref) 1 (Ref)
Pulmonary
extrapulmonary
117 0.67 0.78 (0.53–1.1) 1.0 (0.70–1.5) 371 0.60 0.83 (0.66–1.0) 0.88 (0.71–1.1)
a Ref, reference.
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significant differences were found across phylogenetic lineages
(Table 3).
DISCUSSION
In this study, we observed variations between the infectivity and
clustering indices of different phylogenetic subgroups ofM. tuber-
culosis, M. bovis, and M. africanum after controlling for clinical
and demographic index host factors. M. africanum and M. bovis
showed both significantly lower infectivity and clustering indices
in the FB and native populations, respectively. A significantly
lower infectivity was also observed for the EAI lineage in the larger
FB population.
Our findings around M. africanum are consistent with previ-
ous experiments characterizing its reduced ESAT-6 (early secre-
tory antigenic target-6) immunogenicity and candidate genes be-
hind its attenuated phenotype (17). However, they are only
TABLE 2 Risk factors among native and foreign-born index cases for clustering (number of secondary cases within 2 years of an index case)
Characteristic
Native cohort Foreign-born cohort
No. of
index
cases
Mean no. of
second
cases per
index case
Univariate analysis
Multivariate
analysis,
relative no.
(95% CI)
No.
index
cases
Mean no. of
second
cases per
index case
Univariate analysis
Multivariate
analysis,
relative no.
(95% CI)
Relative no.
(95% CI) P
Relative no.
(95% CI) P
Age, yr
0–19 59 0.46 1.02 (0.53–1.90) 0.001 1.04 (0.56–1.93) 276 0.36 1.32 (0.92–1.92) 0.716 1.42 (0.99–2.03)
20–39 216 0.45 1 (Refa) 1 (Ref) 1,411 0.27 1 (Ref) 1 (Ref)
40–64 267 0.34 0.65 (0.41–0.98) 0.68 (0.46–1.02) 569 0.31 1.14 (0.86–1.51) 1.06 (0.80–1.42)
65 495 0.1 0.22 (0.12–0.33) 0.21 (0.13–0.32) 195 0.08 0.30 (0.16–0.55) 0.30 (0.16–0.55)
Sex
Female 387 0.23 0.87 (0.61–1.23) 0.4255 975 0.23 0.51 (0.29–0.90) 0.019 1.29 (1.01–1.66)
Male 650 0.27 1 (Ref) 1,476 0.31 1 (Ref) 1 (Ref)
Smear positivity
Negative 393 0.18 0.58 (0.40–0.83) 0.0027 0.62 (0.44–0.88) 1,076 0.17 0.48 (0.38–0.61) .0001 0.50 (0.39–0.65)
Positive 644 0.3 1 (Ref) 1 (Ref) 1,375 0.36 1 (Ref) 1 (Ref)
Lineage
Euro-American 756 0.25 1 (Ref) 0.1971 1 (Ref) 1,385 0.3 1 (Ref) 0.081 1 (Ref)
Beijing 73 0.36 1.44 (0.79–2.62) 1.20 (0.68–2.11) 354 0.28 0.93 (0.66–1.32) 1.07 (0.76–1.52)
CAS 28 0.29 1.15 (0.41–3.09) 0.79 (0.30–2.10) 290 0.28 0.93 (0.64–1.36) 0.87 (0.59–1.27)
EAI 118 0.33 1.34 (0.82–2.19) 0.90 (0.54–1.50) 335 0.22 0.74 (0.51–1.07) 0.80 (0.57–1.17)
M. Africanum 8 0.13 0.50 (0.04–5.22) 0.26 (0.03–2.53) 65 0.15 0.52 (0.22–1.21) 0.47 (0.31–0.94)
M. bovis 54 0.06 0.22 (0.06–0.78) 0.11 (0.006–0.56) 22 0.09 0.30 (0.06–1.67) 0.31 (0.06–1.67)
Residency
Urban 785 0.35 1 (Ref) 0.02 1 (Ref) 1,547 0.34 1 (Ref) 0.004 1 (Ref)
Rural 252 0.23 0.65 (0.45–0.94) 0.99 (0.69–1.43) 904 0.24 0.70 (0.55–0.89) 0.77 (0.61–0.99)
Alcohol abuse
No 1,009 0.24 1 (Ref) 0.02 1 (Ref) 2,430 0.28 1 (Ref) 0.964
Yes 28 0.68 2.8 (1.22–6.42) 1.88 (0.89–3.99) 21 0.29 1.93 (0.28–3.74)
Drug abuse
No 1,017 0.25 1 (Ref) 0.05 1 (Ref) 2,398 0.28 1 (Ref) 0.905
Yes 20 0.65 2.64 (0.98–7.03) 1.42 (0.58–3.49) 53 0.26 1.53 (0.42–2.18)
Traveler to country
of endemicity
No 988 0.26 1 (Ref) 0.07 1 (Ref) 2,391 0.28 1 (Ref) 0.167 1 (Ref)
Yes 49 0.10 0.39 (0.14–1.09) 0.26 (0.09–0.70) 60 0.15 0.53 (0.22–1.30) 0.47 (0.20–1.14)
Homeless
No 1,028 0.25 1 (Ref) 0.75 2,401 0.27 1 (Ref) 0.233 1 (Ref)
Yes 9 0.33 1.31 (0.25–6.99) 50 0.44 1.61 (0.74–3.49) 1.19 (0.5–2.56)
Site of disease
Pulmonary 883 0.26 1 (Ref) 0.22 1 (Ref) 1,949 0.29 1 (Ref) 0.129 1 (Ref)
Pulmonary
extrapulmonary
154 0.19 0.94 (0.58–1.53) 502 0.23 0.79 (0.58–1.07) 0.92 (0.67–0.99)
a Ref, reference.
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partially consistent with those from a study conducted in the
Gambia, where M. africanum was shown to transmit equally well
to household contacts but less likely thanM. tuberculosis to prog-
ress to disease (9). While numbers in our native population were
too low to detect any associations in both indices, in the larger FB
cohort, our findings suggest that lower infectivity might also be a
component of the overall lower transmissibility of M. africanum.
Perhaps because of this lower infectivity, we did not observe the
previously reported lower estimate of progression to disease inM.
africanum. Possible explanations for this disparity may lie in the
slightly different definition of infectivity used in the Gambia,
where they used the incidence of TST conversion (using a fol-
low-up period of 3 months) specifically within households as the
outcome. In addition, we may not be comparing exactly the same
genotype; in our FB cohort, only 3 of 183 (1.7%) M. africanum
strains with a known birth country came from the Gambia.
In a cohort of native and FB TB cases in Montreal, the EAI
lineage was also significantly associated with lower number of
TST-positive contacts around index cases and with less clustering
(lower proportion of patients clustering, as defined by identical
RFLP or spoligotypes) inmultivariable analysis (18). It is interest-
ing to observe this trend in our study, which includes only pulmo-
nary cases of EAI, given the association this lineage has with the
extrapulmonary site of disease (16). In a secondary cohort of only
FB cases in the Montreal study, the EAI lineage was significantly
associated with less TST positivity but not with less clustering
(18). This again agrees with our study, where we observed a sig-
nificant association of EAI with lower infectivity but not with
lower clustering. These findings on the EAI genotype are hard to
explain using the molecular epidemiological data from Vietnam,
where approximately 40% of cases are caused by EAI strains and
another 40%, by the Beijing genotype strains (19). If EAI strains
are less successful at infecting, one would expect them to disap-
pear in a few generations and be replaced by other, more fit,
strains. This shift is perhaps occurring at the very moment, as
Beijing genotype isolates have been associated with a lower age of
patients and, hence, with active transmission.
Although M. bovis was spread significantly less in the native
FIG 2 Proportion of cases in which contact investigation was performed by phylogenetic lineage.
TABLE 3 Estimates of progression to disease by risk factor
Characteristic
Median of bootstrapped progression-to-disease
RR (95% CI)
Native cohort Foreign-born cohort
Age, yr
0–19 1.09 (0.54–2.39) 2.05 (1.25–3.74)
20–39 1 (Refa) 1 (Ref)
40–64 0.83 (0.56–1.25) 1.15 (0.79–1.74)
65 0.76 (0.58–0.94) 0.60 (0.40–0.87)
Smear positivity
Negative 0.62 (0.27–1.52) 0.26 (0.17–0.38)
Positive 1 (Ref) 1 (Ref)
Lineage
Euro-American 1 (Ref) 1 (Ref)
Beijing 1.33 (0.60–3.48) 1.32 (0.64–2.35)
CAS 2.47 (0.73–11.26) 0.86 (0.54–1.43)
EAI 1.30 (0.57–3.30) 1.16 (0.82–1.68)
M. africanum 2.07 (0.96–2.11) 1.14 (0.70–2.11)
M. bovis 0.89 (0.66–1.31) 0.92 (0.45–2.00)
Residency
Urban 1 (Ref) 1 (Ref)
Rural 1.67 (1.01–3.01) 1.65 (0.91–2.42)
Alcohol abuse
No 1 (Ref)
Yes 9.78 (1.52–159.85)
Drug abuse
No 1 (Ref)
Yes 3.79 (1.20–22.68)
Traveler to country
with endemicity
No 1 (Ref) 1 (Ref)
Yes 0.77 (0.41–1.30) 0.39 (0.13–0.95)
a Ref, reference.
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population and although the estimates of average number of sec-
ondary cases were lower than other lineages, the fact that there
were three documented secondary cases (from three different in-
dex cases with unique fingerprints) does not rule out the possible
occurrence of transmission ofM. bovis in The Netherlands, where
pasteurization practices have been in place for decades. Ingestion
of unpasteurized dairy products has been suggested as the likely
route of infection in extrapulmonary cases in second-generation
immigrants in The Netherlands who may have traveled back to
their country of origin (20). Yet, all threeM. bovis index cases with
secondary cases in our clustering cohort also hadpulmonaryman-
ifestations; two of these index cases were FB but had no indication
of recent travel to a country of M. bovis endemicity. Indeed, in-
stances of human-to-human transmission of M. bovis have been
documented in other settings (21, 22). Together these observa-
tions suggest that, from a public health perspective, contact inves-
tigation and treatment of pulmonaryM. bovis patients should not
altogether differ from those of M. tuberculosis patients.
Unlike studies conducted in other populations, where the Bei-
jing strain was associatedwith greater virulence and transmissibil-
ity, we did not find that the Beijing strain had higher indices of
infectivity, clustering, or progression to disease in The Nether-
lands (23, 24). This is concordant with other recent studies con-
ducted in similarly low-incidence, immigrant-receiving settings,
such as the United States and Canada, which concluded that Bei-
jing strains are nomore of a public health threat than non-Beijing
strains (25, 26). The observed higher success rate of Beijing strains
may therefore result from circumstances characteristic of high-
prevalence settings, such as mass use of BCG vaccination, devel-
opment of resistance, crowding of the human population, and
other unknown factors.
Other clinical and demographic factors positively associated
with either infectivity or clustering indices, such as smear positiv-
ity, a lower age, and residing in an urban area, have been similarly
described in previous studies (27–29). The significantly lower es-
timate of progression to disease given an elderly source likely re-
flects a lower dose of infection (due to a less close contact) and
propensity for older patients to have older contacts themselves, as
well as the higher proportion of long, latent infections (possibly
associated with lower virulence) in this age category (30). Like-
wise, the significant association between alcohol and drug abuse
with higher estimates of progression to disease can be linked to the
direct effects of both substances on immunity, the indirect effects
of substance-related disorders (i.e., malnutrition), and other po-
tential confounding factors, such as homelessness (31, 32). There
are two possible reasons behind the less-expected association be-
tween use of intravenous drugs and the lower average number of
TST-positive contacts in the native cohort. Contacts of drug abus-
ers are often intravenous drug users themselves, a scenario in
which the accurate definition of a first-ring contact is prone to
misclassification (contacts could bemisclassified as first-ring con-
tacts while they actually do not have much contact with an index
case and, therefore, do not become TST positive). It has also been
described that drug use can comprise cellular immunity (even in
the absence of HIV infection) so that TST sensitivity in drug users
is lower (33, 34).
The low prevalence setting of this study means that the inves-
tigation of the role of theM. tuberculosis genotype on transmission
is less likely to be confounded by a high background infection
pressure, where a TST result is more likely to fail at distinguishing
recent frompast infection. Furthermore, inTheNetherlands there
is no routine BCG vaccination program that could affect the in-
terpretation of TST results, making TST a suitable tool for the
detection of recent M. tuberculosis infection in contact investiga-
tions. This advantage applies solely to the native cohort, however,
as patients in the FB cohort are far more likely to have been BCG
vaccinated than native patients (40% versus 8%, respectively) and
have had higher exposure to TB in their country of origin; both of
these factors might lead to an overestimation of infectivity. It is
encouraging, however, to observe the same trend of lower infec-
tivity in EAI result in another study which did adjust for the prob-
ability of previous latent TB (18). On the other hand, the facts that
FB patients often have FB contacts and that contact tracing in this
group is less efficient imply that we might have also underesti-
mated infectivity (and, by implication, biased the progression to
disease index upward) in this group. The same reasoning applies
to cases of addiction to alcohol and drugs, where an increased
likelihood of homelessness means infected contacts are less likely
to be found.
It is important to remember the potential shortcomings from
the molecular epidemiology data underpinning these findings. A
lack of clinical follow-up data of infected contacts meant that we
were unable to link infected contacts to secondary cases and, thus,
to estimate the proportion of secondary cases infected by a specific
index case. In this low-burden country, however, there is likely a
large overlap in the number of infected contacts around an index
case and the number of secondary cases occurring within 2 years
of that index case. It nevertheless meant that we could not control
for risk factors across the transmission chain, such as rates of la-
tent TB treatment and existing medical risk factors in secondary
cases, which could influence the likelihood of progression to dis-
ease or the susceptibility to infection of the host, respectively.
Studies using a prospective cohort approach (i.e., with access to
household contacts and TST conversion data) that can bypass
some of these issues are warranted to confirm these findings.
In sum, the lower infectivity or overall transmissibility ob-
served in this study for M. bovis, M. africanum, and EAI—all,
ancient lineages—matches the hypothesis that modern strains, as
a consequence of their access to rapidly increasing numbers of
susceptible hosts, have been selected for more rapid disease pro-
gression and transmission (35). Validation of this scenario via
future experimental studies could have important implications on
how TB control efforts may be determined not only by index case
host characteristics, but also by a bacterial signature, such as phy-
logenetic lineage.
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